As Lundbeck and Otsuka count on prescriptions in agitation associated with dementia due to Alzheimer’s disease (AADAD) to ...
Two of the latest product pulls in the U.S.—initiated for separate medicines from Otsuka ICU Medical and Fresenius Kabi in ...
Tanvi Lodhia’s path to pharma marketing may sound familiar to her peers in the industry: Like many of them, for example, she ...
Johnson & Johnson and Legend Biotech are said to have withdrawn an abstract originally planned for next month’s Amer | “At this point, the abstract was withdrawn in alignment with the authors, and we ...
With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...
In a surprise move, the FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new ...
Some three months after merging, Mallinckrodt and Endo have taken the next step toward their joint future by spinning off ...
Amid a rise in misinformation and pseudoscientific beliefs, a new corporate push from Bayer seeks to remind Americans of the ...
Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the ...
Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...
A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...
The TV ad will run through Nov. 16 across major cable channels, including CNN, Fox News and ESPN, a BMS spokesperson told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results